Seaport Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
June 9, 2025
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$225,000,000
Company Info
Market
Neuropsychiatric medicines
Location
Boston, MA, USA
Coinvestors
General Atlantic, T. Rowe Price Associates, Inc., Foresite Capital, Invus, Goldman Sachs Alternatives, CPP Investments, ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health
Company Description

Seaport Therapeutics is a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team.

Links
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement